Journal of Clinical Endocrinology & Metabolism, Vol 80, 370-373, Copyright © 1995 by Endocrine Society

ARTICLES

Properties of a progesterone-induced relaxation in human placental arteries and veins

HA Omar, R Ramirez and M Gibson
Department of Pediatrics, West Virginia University, Morgantown 26506.

To study the effects of progesterone on placental vascular tone, we used isolated (1-2 mm in diameter) placental arteries and veins from term uncomplicated pregnancies. These vessels, incubated in Krebs buffer (pH 7.4) under 5% O2-5% CO2 (balance N2, PO2 approximately 35 torr) and precontracted with serotonin were exposed to incremental doses of progesterone (0.01-30 mumol/L) in the presence or absence of endothelium, 10 mumol/L indomethacin (inhibits prostaglandin synthesis), 10 mumol/L methylene blue (a soluble guanylate cyclase inhibitor), 100 mumol/L nitro-L-arginine (inhibits L-arginine metabolism), 1 mmol/L isobutylmethylxanthine (a cAMP phosphodiesterase inhibitor), or 30 mumol/L mifepristone (RU 38486, an antiprogestin). Progesterone elicited an acute dose-dependent relaxation in both arteries and veins that was not altered by removal of the endothelium or pretreatment with indomethacin, nitro-L-arginine, or methylene blue, excluding a role for prostaglandins, L-arginine products, or cGMP in mediating this relaxation. However, isobutylmethylxanthine significantly enhanced the relaxation in response to progesterone, suggesting a role for cAMP. RU 38486 inhibited the relaxation by 50- 100%, depending on the progesterone dose, consistent with a role for progesterone receptors. These results suggest that progesterone causes a dose-dependent endothelium-independent relaxation of human placental arteries and veins. This relaxation seems to be mediated by a receptor- activated cAMP mechanism and could be physiologically important in maintaining low resistance and adequate blood flow in the placental circulation.

This article has been cited by other articles:

				L. M. Montano, E. Calixto, A. Figueroa, E. Flores-Soto, V. Carbajal, and M. Perusquia Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist L-Type Ca2+ Channel Activity, and 5{beta}-Dihydrotestosterone Restricted to L-Type Ca2+ Channel Blockade Endocrinology, May 1, 2008; 149(5): 2517 - 2526. [Abstract] [Full Text] [PDF]

				B. E. Resch, R. Gaspar, and G. Falkay Application of Electric Field Stimulation for Investigations of Human Placental Blood Vessels Obstet. Gynecol., February 1, 2003; 101(2): 297 - 304. [Abstract] [Full Text] [PDF]

				P. Kristiansson and J.X. Wang Reproductive hormones and blood pressure during pregnancy Hum. Reprod., January 1, 2001; 16(1): 13 - 17. [Abstract] [Full Text] [PDF]

				M. Barbagallo, L. J. Dominguez, G. Licata, J. Shan, L. Bing, E. Karpinski, P. K. T. Pang, and L. M. Resnick Vascular Effects of Progesterone : Role of Cellular Calcium Regulation Hypertension, January 1, 2001; 37(1): 142 - 147. [Abstract] [Full Text] [PDF]

				C. Cudeville, F. Mondon, B. Robert, R. Rebourcet, T.-M. Mignot, C. Benassayag, and F. Ferré Evidence for Progesterone Receptors in the Human Fetoplacental Vascular Tree Biol Reprod, March 1, 2000; 62(3): 759 - 765. [Abstract] [Full Text]

				K. E. Boehm, K. T. Kip, B. P. Grubb, and D. J. Kosinski Neurocardiogenic Syncope: Response to Hormonal Therapy Pediatrics, April 1, 1997; 99(4): 623 - 623. [Full Text] [PDF]